Biotech Is 'Stepchild' of VC Investing

Biotech Is 'Stepchild' of VC Investing Play

Bruce Booth, a partner in the Life Sciences group at Atlas Venture, talks about challenges of investing in biotechnology firms and the company's strategy

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus